Emphysematous Pyelonephritis: Treatment and Management

Emphysematous pyelonephritis (EPN) is a severe, gas-forming kidney infection that can be fatal without timely treatment, but the management approach has shifted dramatically over the past two decades. Where emergency kidney removal was once considered the default, most patients today are treated with antibiotics combined with minimally invasive drainage, and nephrectomy is reserved for those who fail conservative measures. The condition overwhelmingly affects people with diabetes, and the choice of treatment depends on how extensively gas has spread through the kidney tissue, how sick the patient is at presentation, and whether certain high-risk features are present.

What Makes This Infection Different

EPN is not an ordinary kidney infection. The hallmark is gas accumulating inside or around the kidney, produced by bacteria fermenting glucose in the tissue. The main culprits are gut-dwelling bacteria, with Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis being the most frequently isolated organisms.¹ These bacteria use a process called mixed acid fermentation, which produces hydrogen and carbon dioxide as byproducts. Gas analysis from affected kidneys has confirmed this: one study found hydrogen at about 10%, carbon dioxide at 39%, and nitrogen making up most of the remainder.²

The gas itself is a marker of rapid bacterial multiplication, but what makes EPN so dangerous is the tissue destruction that accompanies it. In severe cases, the infection causes vascular clotting and infarction within the kidney, essentially cutting off blood supply to large areas of tissue. Without blood flow, white blood cells and antibiotics cannot reach the infected zone, which is why advanced cases often resist medical treatment alone and may require surgical removal of the dead tissue.³

Who Is at Risk

Diabetes dominates the risk profile for EPN. A meta-analysis pooling data from over 1,100 patients found that roughly 83% were diabetic.⁴ The connection makes biological sense: elevated blood sugar provides the glucose substrate that bacteria need for fermentation, and diabetes impairs immune function and blood vessel health, creating an environment where infection can escalate rapidly.

Women are affected about three times as often as men, likely reflecting the higher baseline rate of urinary tract infections in women.⁵ Beyond diabetes and sex, the same meta-analysis found that about 16% of patients had kidney stones and roughly 21% had some form of urinary tract obstruction.⁴ Any blockage that prevents urine from draining allows bacteria to multiply and gas to accumulate under pressure. People with impaired immune systems from other causes, such as chronic kidney disease, organ transplant recipients on immunosuppressive drugs, or those with HIV, are also vulnerable, though diabetes remains the single biggest predisposing factor by a wide margin.

How It Is Diagnosed and Classified

CT scanning is the definitive diagnostic tool. Plain X-rays or ultrasound can sometimes pick up gas in or around the kidney, but CT is far more sensitive and reveals the extent and distribution of gas with enough detail to guide treatment decisions. One important distinction CT helps make is between emphysematous pyelitis, where gas is confined to the collecting system (the funnel-shaped drainage structures inside the kidney), and true emphysematous pyelonephritis, where gas invades the kidney tissue itself. Pyelitis is generally less severe and carries a better prognosis.⁶

Several classification systems exist to stage EPN severity based on CT findings. The Huang-Tseng system is among the most widely used and divides the disease into classes based on where gas appears and whether it extends beyond the kidney. Earlier work split EPN into two broad types: Type I, with extensive tissue destruction and large gas pockets but little fluid, and Type II, with larger fluid collections alongside the gas.⁷ Type I was historically considered more dangerous, though the picture can evolve during treatment. Regardless of which classification a clinician uses, the staging drives the treatment plan: lower-class disease is more likely to respond to antibiotics and drainage, while higher-class disease carries greater risk and may require escalation to surgery.

First-Line Treatment With Antibiotics and Supportive Care

No matter how far the disease has progressed, initial management always includes aggressive intravenous antibiotics, fluid resuscitation, and tight blood sugar control. Based on the bacteria most commonly responsible for EPN, third-generation cephalosporins are recommended as the go-to empiric antibiotic, meaning they are started before culture results come back.⁸ Once urine and blood cultures identify the specific organism and its drug sensitivities, the antibiotic regimen can be narrowed or adjusted. In an era of rising antibiotic resistance, culture-guided therapy is especially important because resistant strains of E. coli and Klebsiella are increasingly common.

Glycemic control is just as critical as antibiotic choice. Bringing blood sugar down starves the bacteria of the glucose they need for fermentation and helps restore immune function. In one report of bilateral EPN in a diabetic patient, the clinical picture improved within 48 hours once diabetes was brought under control alongside broad-spectrum antibiotics.⁹ This underscores that medical management alone can succeed in selected patients, particularly those with lower-class disease who are hemodynamically stable.

That said, antibiotics alone carry risk. A large meta-analysis of prognostic factors found that medical management without any drainage procedure was itself associated with roughly doubled odds of death compared to approaches that included drainage or surgery.¹⁰ That finding does not mean every patient needs a procedure, but it does mean the threshold for adding drainage should be low, and patients who do not improve within the first 48 to 72 hours of antibiotics alone almost certainly need escalation.

Percutaneous Drainage and Ureteral Stenting

When antibiotics alone are not enough, the next step is drainage. The two main options are percutaneous nephrostomy (inserting a tube through the skin into the kidney under image guidance) and ureteral stenting (placing a small tube through the urinary tract into the kidney from below). Both aim to decompress the infected kidney, allow pus and gas to escape, and restore urine flow.

Percutaneous nephrostomy has been the traditional workhorse. One study of patients treated with percutaneous drainage found a 30-day survival rate of 86%. In patients with lower-class disease, a single drainage procedure was often enough to resolve the infection. Those with more advanced disease were more likely to need a repeat procedure or eventual nephrectomy, but drainage still served as an effective bridge, buying time for patients too sick for immediate surgery.¹¹

Ureteral stenting has emerged as an alternative that some patients tolerate better because it does not require a puncture through the skin. A study comparing stenting to percutaneous drainage found that ureteral stents provided comparable overall success rates.¹² Another series of 15 patients managed with stenting, antibiotics, and glycemic control reported no deaths.¹³ Stenting has also shown promise in specific situations, such as when the gas is confined mainly to the renal pelvis or when vesicoureteral reflux (backward flow of urine from the bladder to the kidney) is contributing to the problem.¹⁴

The choice between percutaneous drainage and stenting often comes down to the anatomy of the obstruction, the patient’s overall stability, and local expertise. If there is a stone blocking the ureter, a stent may bypass it while also draining the kidney. If the infection has destroyed large amounts of tissue and generated thick pus, a wider-bore percutaneous drain may work better. In practice, many centers start with whichever approach the interventional team is most comfortable with and escalate if the patient does not improve.

When Nephrectomy Becomes Necessary

The philosophy around kidney removal has changed substantially. Decades ago, early nephrectomy was considered standard treatment because of EPN’s high mortality. Today, the consensus has moved firmly toward kidney preservation whenever possible. As one group put it, management should be directed toward preserving the kidney and quality of life rather than rendering patients dialysis-dependent when they might retain a functioning organ. In their view, there is no place for immediate nephrectomy; it should be reserved for those who fail conservative treatment.¹⁵

That said, nephrectomy remains necessary in a meaningful number of cases, particularly when extensive tissue has died and cannot recover, or when drainage fails to control sepsis. In one single-center study, surgical treatment (including nephrectomy) was needed in 10 of 22 patients, and all six who underwent nephrectomy survived.¹⁶ The higher mortality seen in the surgical group in that study reflected the fact that surgery was offered to sicker patients who had already failed antibiotics, not that surgery itself was riskier. For patients with Class 3 or higher disease who do not respond to percutaneous drainage, nephrectomy can be lifesaving.

Predicting Who Will Do Poorly

Not all EPN carries the same risk. Identifying the patients most likely to deteriorate helps clinicians decide how aggressively to intervene and how early. A meta-analysis that synthesized data across multiple studies identified several factors strongly linked to death. Sepsis and shock were by far the most dangerous, each associated with roughly 15-fold increased odds of dying. Altered consciousness carried about 12-fold odds, low platelet counts about 8-fold, and acute kidney failure about 5-fold.¹⁰

Higher Huang-Tseng classification (Classes III and IV) also predicted worse outcomes, as did the need for emergency nephrectomy. A separate tertiary-center study confirmed that low platelet counts, septic shock, the need for dialysis, and higher Huang-Tseng stage all predicted death, while thin renal tissue on CT predicted eventual nephrectomy on follow-up.¹⁷ In practical terms, the patient who arrives with low blood pressure, confusion, dropping platelet counts, and extensive gas on CT is in a very different risk category from the stable diabetic patient with a small pocket of gas found incidentally. The former may need drainage within hours and surgical standby; the latter may respond to antibiotics and blood sugar control alone.

Bilateral Disease and Solitary Kidneys

EPN becomes an even more complex problem when it affects both kidneys or the patient’s only functioning kidney. Nephrectomy is not an option in these scenarios without accepting permanent dialysis, which makes kidney-sparing strategies especially important. Case reports have documented successful conservative management of bilateral EPN and EPN in a solitary kidney. In the bilateral case, diabetes control and antibiotics resolved the infection. In the solitary kidney, percutaneous drainage and ureteral catheterization were required, but the kidney was saved.⁹

These situations demand early diagnosis and aggressive medical management. If the infection does not respond quickly, drainage must be pursued without delay. The margin for error is essentially zero when no backup kidney exists, and multidisciplinary input from urology, nephrology, and critical care is essential.

Long-Term Kidney Function After EPN

Surviving the acute episode is not the end of the story. Even when the kidney is preserved, lasting damage to kidney function is a real concern. A retrospective study of 151 patients who survived EPN found that about 15% had poor kidney function on follow-up. The strongest independent predictor was having more than half the kidney tissue involved on initial imaging. Other factors associated with worse long-term function included very high blood sugar at presentation, higher Huang-Tseng class, and persistent gas visible in the kidney on follow-up imaging after treatment.¹⁸

This has practical implications for follow-up care. Patients who survive EPN, particularly those with extensive initial involvement, need ongoing monitoring of kidney function. Blood sugar management remains critical long after discharge, both to protect the recovering kidney and to reduce the risk of recurrence. Repeat imaging may be warranted to confirm that gas has cleared, since persistent gas signals ongoing tissue compromise and predicts future functional decline.

Adjunctive and Emerging Therapies

Standard treatment revolves around antibiotics, drainage, and surgery as needed, but a few adjunctive approaches have appeared in case reports. In one patient who developed necrotizing fasciitis of the abdominal wall as a complication of EPN, negative-pressure wound therapy was used to manage the wound, and hyperbaric oxygen therapy was employed to enhance bacterial killing, tissue oxygenation, and healing.¹⁹ These are not routine interventions and their role in typical EPN is unproven, but they illustrate the kind of creative problem-solving that complicated cases can demand.

Hyperbaric oxygen is theoretically attractive because the infection thrives in low-oxygen, tissue-damaged environments, and flooding those environments with oxygen could help shift the balance in favor of the host’s immune response. However, access to hyperbaric chambers is limited, and transporting critically ill patients to one carries its own risks. For now, these remain salvage options for exceptional cases rather than standard additions to the treatment toolkit.

Why the Shift Away From Early Nephrectomy Matters

The move toward conservative management is not just an academic preference. Many EPN patients already have compromised kidney function from diabetes, and removing a kidney pushes them closer to or into end-stage kidney disease requiring dialysis. Dialysis carries its own substantial risks and dramatically affects quality of life. By preserving the kidney when possible, even if it recovers only partial function, clinicians give patients a meaningful chance at avoiding that outcome.

The evidence supporting this shift is now fairly robust. Multiple series have shown that percutaneous drainage combined with antibiotics can resolve EPN in a large proportion of patients without removing the kidney.¹⁵ Ureteral stenting adds another kidney-sparing tool to the arsenal.¹³ The key is recognizing early which patients can be managed conservatively and which cannot. Patients who arrive in septic shock with extensive bilateral disease and low platelets are not good candidates for a wait-and-see approach with antibiotics alone. But for the stable patient with localized gas and no alarming lab findings, attempting kidney preservation is not only reasonable but preferred.

The decision framework ultimately rests on a simple hierarchy: start with antibiotics and supportive care, add drainage early if the patient does not respond or if the disease is moderate to severe, and proceed to nephrectomy only when the kidney is unsalvageable or the patient’s life is at stake. Keeping that ladder in mind, along with the prognostic factors that predict who will need to climb it, gives both patients and clinicians a clearer path through what remains one of the most dangerous urinary tract infections.

1
PubMed Central. Emphysematous pyelonephritis: classification, management, and prognosis
2
PubMed. Gas in hepatic veins: a rare and critical presentation of emphysematous pyelonephritis
3
JAMA Internal Medicine. Emphysematous Pyelonephritis: Clinicoradiological Classification, Management, Prognosis, and Pathogenesis
4
PubMed. A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis
5
PubMed Central. Emphysematous Pyelonephritis in a Diabetic Patient with Remarkable Radiological Findings and Excellent Outcome without Surgical Intervention or Drainage
6
PubMed Central. Air in the kidney: between emphysematous pyelitis and pyelonephritis
7
PubMed. Emphysematous pyelonephritis- conversion of type i to type II appearance on serial CT studies
8
PubMed Central. Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis
9
PubMed. Successful conservative management of emphysematous pyelonephritis, bilateral or in a solitary kidney
10
PubMed. Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis
11
PubMed Central. Percutaneous drainage for non-operative management of emphysematous pyelonephritis: Clinical characteristics and predictors of success
12
Urologia Internationalis. Is JJ Ureteral Stenting Inferior to Percutaneous Nephrostomy as a Drainage Method in Emphysematous Pyelonephritis?
13
PubMed Central. Double J stenting: A rewarding option in the management of emphysematous pyelonephritis
14
Urology Case Reports. Complicated case of bilateral emphysematous pyelonephritis and emphysematous cystitis successfully treated with transurethral drainage and ureteral stents
15
PubMed Central. Emphysematous pyelonephritis: Is nephrectomy warranted?
16
Indian Journal of Nephrology. Emphysematous pyelonephritis: A single center study
17
PubMed Central. Predictors of mortality and nephrectomy in emphysematous pyelonephritis: a tertiary care centre study
18
PubMed Central. Predictors of poor kidney function in patients with emphysematous pyelonephritis: a retrospective observational study
19
PubMed Central. Emphysematous pyelonephritis-related delayed abdominal wall necrotizing fasciitis: A case report